[Treatment of irritable bowel syndrome with dicetelium and spasmomen].
The aim of the study was to compare clinical efficacy of new spasmolytics--pinaverium bromide (dicetel, Solvay Pharma) and otilonium bromide (spasmomen, Menarini-Berlin-Chemie)--in the treatment of irritable bowel syndrome. Effects appearing during the treatment with anxiolytic drug tofisopam (grandaxin, Egis) after using dicetel and spasmomen were also studied. The results indicate marked clinical efficiency of dicetel and spasmomen which improve vegetative functions and psychoemotional status. Grandaxin provides further improvement of clinical symptoms and additionally corrects psychoemotional status.
Nedogoda
S V
SV
Parshev
V V
VV
D000328:Adult; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000008:administration & dosage / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D005765:Gastrointestinal Agents; D009025:Morpholines; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; C013934:octylonium; C013199:pinaverium
Lechenie lindroma razdrazhennoĭ tolstoĭ kishki s ispol'zovaniem ditsetelia i spazmomena.